Clinical trials
Cancer (With or Without Metastasis) clinical trials
Below are recruiting cancer (with or without metastasis) clinical trials, each written for real people, not researchers. We’re tracking 13,069 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06634966RecruitingPhase 3
Lung cancer surgery study for specific nodule types
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT04049214Recruiting
Mindfulness program during breast cancer surgery
This trial tests whether a structured mindfulness program before and after breast cancer surgery can reduce stress and improve how patients feel and cope. You may be offered mindfulness materials to use around the time of your operation.
Newport Beach, CaliforniaAges 18 years+ - NCT05487391RecruitingPhase 3
QL1706 plus chemo after lung cancer surgery
This trial studies whether a study drug called QL1706 added to standard platinum chemotherapy can lower the chance of lung cancer coming back after surgery. It targets people with stage II to IIIB non-small cell lung cancer who have had their tumor fully removed.
ShanghaiAges 18 years+ - NCT05902559Recruiting
Study of new lung-check biomarkers in older adults
This study looks at new blood or test “biomarkers” to understand how well targeted lung health checks work. You join if you’re already attending the NHS lung health check program and can consent.
LondonAges 55–74 - NCT06464913RecruitingPhase 2
Chest wall radiation omission after breast implant reconstruction
This study tests whether skipping chest wall radiation after breast implant reconstruction is safe and effective for patients with stage T1-2N1 breast cancer. It may help avoid side effects from radiation while still controlling the cancer.
Hangzhou, ZhejiangAges 18–70 - NCT06632431Recruiting
Endometrial cancer study comparing old and new staging systems
This study looks at tissue samples and medical records of people with endometrial cancer who had surgery between 2018 and 2022. It aims to compare older and newer ways of describing the cancer stage to help improve treatment decisions.
AsyutAges 18 years+ - NCT06638593Recruiting
Comparing open vs. robotic surgery for pelvic masses up to 8cm
This study compares two types of minimally invasive surgery—traditional laparoscopic (keyhole) versus robotic-assisted—for removing complex ovarian cysts or masses up to 8cm that haven't spread. The goal is to see which approach might offer better recovery and outcomes for women with these growths.
GuildfordAges 18–100 - NCT07706673Enrolling by invitationPhase 4
Long-term follow-up for HPV vaccine study participants
This study checks on people who got one or two doses of the HPV vaccine (Gardasil 9) during the earlier ESCUDDO study. It helps researchers see how well the vaccine protects over many years, which might lead to simpler vaccination schedules.
Liberia, Guanacaste ProvinceAges 18 years+ - NCT07711847Recruiting
Prone positioning for faster breast radiation therapy
This trial tests a personalized prone-immobilization device for partial breast radiation after surgery. It aims to make treatment more comfortable and accurate for patients who have had breast-conserving surgery.
New York, New YorkAges 40 years+ - NCT07708935Recruiting
Study of young patients with solid tumors in China
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
ShanghaiAges 18–80 - NCT07712107Recruiting
Gastrointestinal Cancer Screening Study Using Combined Detection
This study tests a new way to screen for stomach and digestive cancers using a combination of tests. It compares different screening plans to see which works best for people in their middle years.
Zhaoqing, GuangdongAges 45–74 - NCT07707232Recruiting
Using AI to read PSMA PET/CT reports for prostate cancer
This trial uses a computer program (large language model) to help doctors read Chinese PSMA PET/CT reports. The goal is to see if the AI can accurately identify key details about prostate cancer, like where it has spread, which may help make staging and treatment decisions faster.
Wenzhou, ZhejiangAges 18 years+ - NCT07710495Recruiting
Exercise program for pancreatic cancer patients before surgery
This trial tests whether a supervised exercise program before Whipple surgery can improve recovery and outcomes in people with pancreatic cancer. If you are scheduled for this surgery, exercise may help you get stronger before the operation.
Guildford, SurreyAges 18 years+ - NCT07707401Recruiting
WeChat neck exercises for recovery after thyroid surgery
This study tests whether simple neck exercises, guided through the WeChat app, can help you recover more quickly after thyroid surgery. If you have no serious complications and don't have neck problems, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07707245Recruiting
Finding biomarkers in lung disease and lung cancer
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Milan, MilanAges 18 years+ - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT07708571Recruiting
Coaching program for women on ribociclib and aromatase inhibitor
This study tests whether a coaching program based on personality types helps women with early-stage hormone receptor-positive, HER2-negative breast cancer stick to their treatment plan. Participants must be taking ribociclib (Kisqali) and an aromatase inhibitor, and their cancer must not have spread to other organs.
Augsburg, BavariaAges 18 years+ - NCT06637007RecruitingPhase 2
Chidamide plus AK112 for advanced sarcoma after first treatment
This trial tests two new drugs (chidamide and AK112) together for people with advanced bone or soft tissue sarcoma that has not responded to standard first-line treatment. The goal is to see if this combination can shrink tumors or slow their growth.
Taiyuan, ShanxiAges 18–75 - NCT06637267Recruiting
Testing a new blood test to improve prostate cancer risk assessment
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
Aarau, Canton of AargauAges 45–80 - NCT06641531Recruiting
How common are abnormal Pap smears?
This study looks at how common abnormal Pap smears (cervical cancer screening tests) are in women. It is for women who are due for screening or need follow-up after a previous abnormal result.
SohagAges 21–60 - NCT06636747Recruiting
High-resolution diffusion MRI for prostate imaging
This study looks at new types of MRI scans to get clearer images of the prostate. It may help doctors better understand prostate health and find problems.
Nanjing, JiangsuAges 55 years+ - NCT04979156Recruiting
Laser removal of bladder tumors in one piece
This trial studies using a specific laser technique to remove bladder tumors “en bloc” (in one piece) during a procedure. It may help reduce leftover tumor tissue and improve how safely the tumor can be removed for people with certain small, papillary bladder tumors.
Kansas City, KansasAges 18 years+ - NCT06644248Recruiting
AI study for detecting cervical cancer from colposcopy images
This study is testing a new artificial intelligence (AI) system to detect cervical cancer from images taken during a colposcopy exam. If successful, it could help doctors identify cancer earlier and more accurately.
DhakaAges 18 years+ - NCT06644352Recruiting
Comparing right vs. left chest surgery for junction cancer
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
BeijingAges 18–80
Hear when a new Cancer (With or Without Metastasis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer (with or without metastasis)?
- Yes. Clin2 currently lists 13,069 recruiting cancer (with or without metastasis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer (with or without metastasis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer (with or without metastasis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Non Small Cell Lung Cancer
- Liver Metastasis Colon Cancer
- Gastric Cancer, Gastroesophageal Junction Cancer
- Lung Cancer Non-Small Cell Cancer (NSCLC)
- Colorectal Cancer Liver Metastasis
- Breast Cancer (Triple Negative Breast Cancer (TNBC))
- Leptomeningeal Metastasis of Breast Cancer
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.